Serum cardiac markers response to biphasic and monophasic electrical cardioversion for supraventricular tachyarrhythmia-a randomised study

Resuscitation

Volumn 70, Issue 3, 2006, Pages 423-431

  Skulec, Roman ^a   Belohlavek, Jan ^a   Kovarnik, Tomas ^a   Kolar, Jiří ^a   Gandalovicova, Jana ^a   Dytrych, Vladimir ^a   Linhart, Ales ^a   Aschermann, Michael ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Biphasic; Cardiac marker; Electrical cardioversion; Monophasic

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; MYOGLOBIN; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENERGY; ENZYME BLOOD LEVEL; FEMALE; FRACTIONATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; SUPRAVENTRICULAR TACHYCARDIA;

ATRIAL FIBRILLATION; ATRIAL FLUTTER; BIOLOGICAL MARKERS; ELECTRIC COUNTERSHOCK; HUMANS; TACHYCARDIA, ECTOPIC ATRIAL; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 33747884205     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2006.02.003     Document Type: Article

References (27)

1. Lown B., Amarasingham R., and Newman J. New method for terminating cardiac arrhythmias: use of synchronized capacitor discharge. JAMA 182 (1962) 548-555
2. Carunchio A., Burattini M., Coletta C., et al. Electrical cardioversion for atrial fibrillation: advantages of the transthoracic biphasic method. Ital Heart J 3 (2002) 638-645
3. Neri G., Alitto F., Zamprogno R., et al. Efficacy and safety of ambulatory electric cardioversion of atrial fibrillation with monophasic and biphasic shock. Ital Heart J 2 (2001) 1315-1318
4. Grubb N.R., Cuthbert D., Cawood P., Flapan A.D., and Fox K.A. Effect of DC shock on serum levels of total creatine kinase, MB-creatine kinase mass and troponin T. Resuscitation 36 (1998) 193-199
5. Greaves K., and Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 80 (1998) 226-228
6. Georges J.L., Spentchian M., Caubel C., et al. Time course of troponin I, myoglobulin, and cardiac enzyme release after electrical cardioversion. Am J Cardiol 78 (1996) 825-826
7. Bonnefoy E., Chevalier P., Kirkorian G., Guidolet J., Marchand A., and Touboul P. Cardiac troponin I does not increase after cardioversion. Chest 111 (1997) 15-18
8. Jakobsson J., Odmansson I., and Nordlander R. Enzyme release after elective cardioversion. Eur Heart J 11 (1990) 749-752
9. Neumayr G., Hagn C., Ganzer H., et al. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 80 (1997) 1367-1369
10. Allan J.J., Feld R.D., Russell A.A., et al. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 30 (1997) 1052-1056
11. Rao A.C., Naeem N., John C., Collinson P.O., Canepa-Anson R., and Joseph S.P. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 80 (1998) 229-230
12. Neumayr G., Schratzberger P., Friedrich G., Ganzer H., and Wiedermann C.J. Effect of electrical cardioversion on myocardial cells in patients in intensive care. BMJ 316 (1998) 1207-1210
13. Lund M., French J.K., Johnson R.N., Williams B.F., and White H.D. Serum troponins T and I after elective cardioversion. Eur Heart J 21 (2000) 245-253
14. Gheno G., Zeppellini R., De Domenico R., and Cucchini F. Threshold energy dose for enzyme release after direct-current countershock. Int J Cardiol 55 (1996) 163-167
15. Fuster V., Ryden L.E., Asinger R.W., et al. American College of Cardiology/American Heart Association/European Society of Cardiology Board. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 38 (2001) 1231-1266
16. Mittal S., Ayati S., Stein K.M., et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation 101 (2000) 1282-1287
17. Ricard P., Levy S., Boccara G., Lakhal E., and Bardy G. External cardioversion of atrial fibrillation: comparison of biphasic vs. monophasic waveform shocks. Europace 3 (2001) 96-99
18. Page R.L., Kerber R.E., Russell J.K., et al. BiCard Investigators. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation: the results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol 39 (2002) 1956-1963
19. Wilson C.M., Allen J.D., Bridges J.B., and Adgey A.A. Death and damage caused by multiple direct current shocks: studies in an animal model. Eur Heart J 9 (1988) 1257-1265
20. Trouton T.G., Allen J.D., Yong L.K., Rooney J.J., and Adgey A.A. Metabolic changes and mitochondrial dysfunction early following transthoracic countershock in dogs. Pacing Clin Electrophysiol 12 (1989) 1827-1834
21. Trouton T.G., Allen J.D., and Adgey A.A. Oxidative metabolism and myocardial blood flow changes after transthoracic DC countershocks in dogs. Eur Heart J 13 (1992) 1431-1440
22. Trouton T.G., Allen J.D., Young I.S., Trimble E.R., and Adgey A.A. Altered cardiac oxygen extraction, lactate production and coronary blood flow after large dose transthoracic DC countershocks. Pacing Clin Electrophysiol 16 (1993) 1304-1309
23. Konttinen A., Hupli V., Louhija A., and Hartel G. Origin of elevated serum enzyme activities after direct-current countershock. N Engl J Med 281 (1969) 231-234
24. Del Carlo C.H., and O'Connor C.M. Cardiac troponins in congestive heart failure. Am Heart J 138 (1999) 646-653
25. Freda B.J., Tang W.H., Van Lente F., Peacock W.F., and Francis G.S. Cardiac troponins in renal insufficiency: review and clinical implications. J Am Coll Cardiol 40 (2002) 2065-2071
26. Bhayana V., Gougoulias T., Cohoe S., and Henderson A.R. Discordance between results for serum troponin T and troponin I in renal disease. Clin Chem 41 (1995) 312-317
27. Mair J., Morandell D., Genser N., et al. Equivalent early sensitivities of myoglobin, creative kinase MB mass, creative kinase isoform ratios, and cardiac troponins I and T for acute myocardial infarction. Clin Chem 41 (1995) 1266-1272